COMP <GO>
ACLS vs NVDA // EV/EBITDA & P/E VALUATION
Axcelis Technologies Inc. (NASDAQ) VS. NVIDIA Corporation (NASDAQ) • 15-METRIC TALLY: ACLS 2
— NVDA 11
▲ EV/EBITDA & P/E VALUATION LEADER: NVDA
LAST: $112.02 (-1.50%) • MKT CAP: $3.46B
valuation
25.7x
LAST: $213.66 (-0.80%) • MKT CAP: $5.15T
valuation
23.2x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ACLS VS. NVDA)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ACLS | NVDA | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 44.90% | 74.67% | -29.77 | NVDA | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 10.60% | 65.06% | -54.46 | NVDA | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 25.7x | 23.2x | +2.49 | NVDA | /valuation <GO> |
| Free Cash Flow Yield | 3.09% | 2.58% | +0.51 | ACLS | /fcf-yield <GO> |
| Operating Margin | 14.20% | 65.21% | -51.01 | NVDA | /operating-margins <GO> |
| Net Profit Margin | 14.30% | 63.66% | -49.36 | NVDA | /net-margins <GO> |
| Revenue Growth (YoY) | -17.60% | 83.38% | -100.98 | NVDA | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.02% | -0.02 | NVDA | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 8.43 | 19.52 | -11.09 | NVDA | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 4/9 | +1.00 | ACLS | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 9.01% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 35.1 | 51.1 | -15.95 | NVDA | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 2.04 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 26.8x | 17.0x | +9.78 | NVDA | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $3.46B | $5.15T | -$5.15T | NVDA | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ACLS REV | NVDA REV | ACLS GROSS % | NVDA GROSS % | ACLS FCF | NVDA FCF |
|---|---|---|---|---|---|---|
| FY 2026 | — | $215.94B | — | 71.1% | — | $96.68B |
| FY 2025 | $839.0M | $130.50B | 44.9% | 75.0% | $107.0M | $60.85B |
| FY 2024 | $1.02B | $60.92B | 44.7% | 72.7% | $128.6M | $27.02B |
| FY 2023 | $1.13B | $26.97B | — | 56.9% | $156.9M | $3.81B |
| FY 2022 | — | $26.91B | — | 64.9% | — | $8.13B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ACLS // BETA —
NVDA // BETA 2.04